Year |
Citation |
Score |
2022 |
Liang Z, Soriano-Castell D, Kepchia D, Duggan BM, Currais A, Schubert D, Maher P. Corrigendum to "Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors" [Free Radic. Biol. Med. 180 (2020 Feb 20) 33-51]. Free Radical Biology & Medicine. 184: 16. PMID 35381547 DOI: 10.1016/j.freeradbiomed.2022.03.022 |
0.336 |
|
2019 |
Kepchia D, Xu P, Terryn R, Castro A, Schürer SC, Leal WS, Luetje CW. Use of machine learning to identify novel, behaviorally active antagonists of the insect odorant receptor co-receptor (Orco) subunit. Scientific Reports. 9: 4055. PMID 30858563 DOI: 10.1038/S41598-019-40640-4 |
0.654 |
|
2017 |
Kepchia D, Sherman B, Haddad R, Luetje CW. Mammalian odorant receptor tuning breadth persists across distinct odorant panels. Plos One. 12: e0185329. PMID 28945824 DOI: 10.1371/Journal.Pone.0185329 |
0.615 |
|
2017 |
Kepchia D, Moliver S, Chohan K, Phillips C, Luetje CW. Correction: Inhibition of insect olfactory behavior by an airborne antagonist of the insect odorant receptor co-receptor subunit. Plos One. 12: e0183009. PMID 28771601 DOI: 10.1371/journal.pone.0183009 |
0.624 |
|
2017 |
Kepchia D, Moliver S, Chohan K, Phillips C, Luetje CW. Inhibition of insect olfactory behavior by an airborne antagonist of the insect odorant receptor co-receptor subunit. Plos One. 12: e0177454. PMID 28562598 DOI: 10.1371/journal.pone.0177454 |
0.662 |
|
Low-probability matches (unlikely to be authored by this person) |
2019 |
Schubert D, Kepchia D, Liang Z, Dargusch R, Goldberg J, Maher P. Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer's Disease. Molecular Neurobiology. PMID 31104297 DOI: 10.1007/s12035-019-1637-8 |
0.207 |
|
2022 |
Liang Z, Soriano-Castell D, Kepchia D, Duggan BM, Currais A, Schubert D, Maher P. Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors. Free Radical Biology & Medicine. 180: 33-51. PMID 34999187 DOI: 10.1016/j.freeradbiomed.2022.01.001 |
0.186 |
|
2022 |
Currais A, Kepchia D, Liang Z, Maher P. The Role of AMP-activated Protein Kinase in Oxytosis/Ferroptosis: Protector or Potentiator? Antioxidants & Redox Signaling. PMID 35243895 DOI: 10.1089/ars.2022.0013 |
0.078 |
|
2022 |
Kepchia D, Huang L, Currais A, Liang Z, Fischer W, Maher P. The Alzheimer's disease drug candidate J147 decreases blood plasma fatty acid levels via modulation of AMPK/ACC1 signaling in the liver. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 147: 112648. PMID 35051863 DOI: 10.1016/j.biopha.2022.112648 |
0.078 |
|
2021 |
Kepchia D, Currais A, Dargusch R, Finley K, Schubert D, Maher P. Geroprotective effects of Alzheimer's disease drug candidates. Aging. 13. PMID 33550278 DOI: 10.18632/aging.202631 |
0.076 |
|
2010 |
Damerla RR, Knickelbein KE, Kepchia D, Jackson A, Armitage BA, Eckert KA, Opresko PL. Telomeric repeat mutagenicity in human somatic cells is modulated by repeat orientation and G-quadruplex stability. Dna Repair. 9: 1119-29. PMID 20800555 DOI: 10.1016/J.Dnarep.2010.07.014 |
0.072 |
|
2020 |
Kepchia D, Huang L, Dargusch R, Rissman RA, Shokhirev MN, Fischer W, Schubert D. Diverse proteins aggregate in mild cognitive impairment and Alzheimer's disease brain. Alzheimer's Research & Therapy. 12: 75. PMID 32560738 DOI: 10.1186/S13195-020-00641-2 |
0.01 |
|
Hide low-probability matches. |